Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CVS Health (CVS)

CVS Health plans to split into two companies by 1H 2028 and raised 2026 guidance

Positive Impact 4 of 5 restructuring

CVS Health announced its intention to separate into two independent, publicly traded companies in a transaction intended to be tax-free to the company and shareholders. The separation is expected to be completed in the first half of 2028, subject to customary conditions, and the company also announced third quarter 2026 results and raised its full-year 2026 guidance in a separate release.

Key points

  • Healthcare solutions company (CVS Health) would include Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health; David Joyner would be Chairman and CEO.
  • CVS Pharmacy would include about 9,000 CVS pharmacies, mail pharmacy, MinuteClinic and Health100; Prem Shah would be CEO.
  • Separation expected to be completed in the first half of 2028, subject to Board approval, effectiveness of a Form 10 registration statement and tax confirmation.
  • Company raised full-year 2026 guidance in a separate press release issued the same day; the amount of the raise is not stated in this filing.

The filing

CompanyCVS Health (CVS)
Form8-K, current report
Filed with the SECNov 4, 2026, 6:34 AM ET
Accession number0001193125-26-446150

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.